| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |